Skip to main content
Erschienen in: Allergo Journal 8/2012

05.01.2013 | Übersicht

Welche Rolle spielt das natürliche Immunsystem bei atopischer Dermatitis?

Bestandsaufnahme und Ausblick

verfasst von: Thomas Volz, Prof. Dr. Tilo Biedermann

Erschienen in: Allergo Journal | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Zusammenfassung

In den letzten Jahren konnte eine Vielzahl von Mechanismen aufgedeckt werden, mit denen das angeborene Immunsystem in der Lage ist, Mikroorganismen zu erkennen und eine erste schnelle Immunantwort auszulösen. Dabei zeigte sich auch, dass das angeborene Immunsystem nicht nur frühzeitig reagiert, sondern vor allem auch die nachfolgend erworbene (adaptive) Immunität induziert und qualitativ beeinflusst. Diese Einblicke in grundlegende Mechanismen erlaubten auch, Pathogenese und Verlauf der atopischen Dermatitis besser zu verstehen. Patienten mit atopischer Dermatitis zeigen meist eine gestörte Hautbarriere, zusätzlich eine massive läsionale Besiedelung mit Bakterien sowie Störungen im Bereich der angeborenen und erworbenen Immunantwort. In ihrer Gesamtheit führen diese Veränderungen der Reaktionsbereitschaft des Oberflächenorgans Haut zu einer sich selbst verstärkenden und die Erkrankung charakterisierenden Entzündungsreaktion. Das Verständnis der zugrunde liegenden immunologischen Mechanismen bei atopischer Dermatitis ermöglicht es auch, für diese Erkrankung neue Therapieoptionen zu entwickeln, inklusive einer gezielten Regulation des Immunsystems. Basierend auf dem Verständnis der angeborenen Immunität wird dem Kliniker in dieser Übersichtsarbeit ein Einblick in sich entwickelnde neue Konzepte zu Krankheitsverständnis und Therapiestrategien bei atopischer Dermatitis gegeben.

Literatur
  1. Anderson KV, Jürgens G, Nüsslein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll gene product. Cell 1985; 42: 779–89PubMedView Article
  2. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008; 8: 411–20PubMedView Article
  3. Barnes KC. An update on the genetics of atopic dermatitis: scratching the surface in 2009. J Allergy Clin Immunol 2010; 125: 16–29.e1–11; quiz 30–1PubMedView Article
  4. Barnes MJ, Powrie F. Regulatory T cells reinforce intestinal homeostasis. Immunity 2009; 31: 401–11PubMedView Article
  5. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27: 20–1PubMedView Article
  6. Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008; 453: 1051–7PubMedView Article
  7. Biedermann T. Dissecting the role of infections in atopic dermatitis. Acta Derm Venereol. 2006; 86: 99–109PubMed
  8. Biedermann T, Schwärzler C, Lametschwandtner G, Thoma G, Carballido-Perrig N, Kund J, De Vries JE, Rot A, Carballido JM. Targeting CLA/E-selectin interactions prevents CCR4-mediated recruitment of human Th2 memory cells to human skin in vivo. Eur J Immunol 2002; 32: 3171–80PubMedView Article
  9. Biedermann T, Röcken M, Carballido JM. TH1 and TH2 lymphocyte development and regulation of TH cell-mediated immune responses of the skin. J Investig Dermatol Symp Proc 2004; 9: 5–14PubMedView Article
  10. Biedermann T, Lametschwandtner G, Tangemann K, Kund J, Hinteregger S, Carballido-Perrig N, Rot A, Schwärzler C, Carballido JM. IL-12 instructs skin homing of human Th2 cells. J Immunol 2006; 177: 3763–70PubMed
  11. Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011; 242: 233–46PubMedView Article
  12. Breuer K, Häussler S, Kapp A, Werfel T. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol 2002; 147: 55–61PubMedView Article
  13. Campbell JJ, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P, Andrew DP, Warnke R, Ruffing N, Kassam N, Wu L, Butcher EC. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999; 400: 776–80PubMedView Article
  14. Cogen AL, Nizet V, Gallo RL. Skin microbiota: a source of disease or defence? Br J Dermatol 2008; 158: 442–55PubMedView Article
  15. Coombes JL, Powrie F. Dendritic cells in intestinal immune regulation. Nat Rev Immunol 2008; 8: 435–46PubMedView Article
  16. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science 2009; 326: 1694–7PubMedView Article
  17. Delves PJ, Roitt IM. The immune system. First of two parts. N Engl J Med 2000; 343: 37–49PubMedView Article
  18. Dudda JC, Martin SF. Tissue targeting of T cells by DCs and microenvironments. Trends Immunol 2004; 25: 417–21PubMedView Article
  19. Dudda JC, Lembo A, Bachtanian E, Huehn J, Siewert C, Hamann A, Kremmer E, Forster R, Martin SF. Dendritic cells govern induction and reprogramming of polarized tissue-selective homing receptor patterns of T cells: important roles for soluble factors and tissue microenvironments. Eur J Immunol 2005; 35: 1056–65PubMedView Article
  20. Fölster-Holst R, Weidinger S. Neues und Bewährtes zur Therapie des atopischen Ekzems. Allergo J 2012; 21: 404–14View Article
  21. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007; 104: 13780–5PubMedView Article
  22. Geuking MB, Cahenzli J, Lawson MA, Ng DC, Slack E, Hapfelmeier S, Mccoy KD, Macpherson AJ. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 2011; 34: 794–806PubMedView Article
  23. Grewe M, Bruijnzeel-Koomen CA, Schöpf E, Thepen T, Langeveld-Wildschut AG, Ruzicka T, Krutmann J. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998; 19: 359–61PubMedView Article
  24. Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol 2011; 9: 244–53PubMedView Article
  25. Gueniche A, Knaudt B, Schuck E, Volz T, Bastien P, Martin R, Röcken M, Breton L, Biedermann T. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study. Br J Dermatol 2008; 159: 1357–63PubMedView Article
  26. Günther C, Bello-Fernandez C, Kopp T, Kund J, Carballido-Perrig N, Hinteregger S, Fassl S, Schwärzler C, Lametschwandtner G, Stingl G, Biedermann T, Carballido JM. CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells. J Immunol 2005; 174: 1723–8PubMed
  27. Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994; 94: 870–6PubMedView Article
  28. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, Lambrecht BN. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 2009; 15: 410–6PubMedView Article
  29. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, Horiuchi T, Tomizawa H, Takeda K, Akira S. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002; 3: 196–200PubMedView Article
  30. Hennessy EJ, Parker AE, O’neill LA. Targeting Toll-like receptors: emerging therapeutics? Nat Rev Drug Discov 2010; 9: 293–307PubMedView Article
  31. Homey B, Alenius H, Müller A, Soto H, Bowman EP, Yuan W, Mcevoy L, Lauerma AI, Assmann T, Bunemann E, Lehto M, Wolff H, Yen D, Marxhausen H, To W, Sedgwick J, Ruzicka T, Lehmann P, Zlotnik A. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002; 8: 157–65PubMedView Article
  32. Howell MD, Gallo RL, Boguniewicz M, Jones JF, Wong C, Streib JE, Leung DY. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 2006; 24: 341–8PubMedView Article
  33. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010; 327: 291–5PubMedView Article
  34. Jurk M, Heil F, Vollmer J, Schetter C, Krieg AM, Wagner H, Lipford G, Bauer S. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 2002; 3: 499PubMedView Article
  35. Kanzler H, Barrat FJ, Hessel EM, Coffman RL. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 2007; 13: 552–9PubMedView Article
  36. Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003; 3: 984–93PubMedView Article
  37. Kaufmann SH. The contribution of immunology to the rational design of novel antibacterial vaccines. Nat Rev Microbiol 2007; 5: 491–504PubMedView Article
  38. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11: 373–84PubMedView Article
  39. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011; 34: 637–50PubMedView Article
  40. Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 2007; 8: 191–7PubMedView Article
  41. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B, Cao W, Su B, Nestle FO, Zal T, Mellman I, Schroder JM, Liu YJ, Gilliet M. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007; 449: 564–9PubMedView Article
  42. Larche M, Akdis CA, Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006; 6: 761–71PubMedView Article
  43. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002; 416: 603–7PubMedView Article
  44. Lee HK, Iwasaki A. Innate control of adaptive immunity: dendritic cells and beyond. Semin Immunol 2007; 19: 48–55PubMedView Article
  45. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996; 86: 973–83PubMedView Article
  46. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003; 361: 151–60PubMedView Article
  47. Liu YJ. Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 2006; 203: 269–73PubMedView Article
  48. Matsui K, Nishikawa A, Suto H, Tsuboi R, Ogawa H. Comparative study of Staphylococcus aureus isolated from lesional and non-lesional skin of atopic dermatitis patients. Microbiol Immunol 2000; 44: 945–7PubMed
  49. Medzhitov R. Approaching the asymptote: 20 years later. Immunity 2009; 30: 766–75PubMedView Article
  50. Miller LS. Toll-like receptors in skin. Adv Dermatol 2008; 24: 71–87PubMedView Article
  51. Mora JR, Cheng G, Picarella D, Briskin M, Buchanan N, Andrian UH von. Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues. J Exp Med 2005; 201: 303–16PubMedView Article
  52. Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ. Skin immune sentinels in health and disease. Nat Rev Immunol 2009; 9: 679–91PubMed
  53. O’Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006; 7: 688–93PubMedView Article
  54. O’Neill LA. How Toll-like receptors signal: what we know and what we don’t know. Curr Opin Immunol 2006; 18: 3–9PubMedView Article
  55. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347: 1151–60PubMedView Article
  56. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, O’Regan GM, Watson RM, Cecil JE, Bale SJ, Compton JG, Digiovanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, El Houate B, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, McLean WH. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441–6PubMedView Article
  57. Pamer EG. Immune responses to commensal and environmental microbes. Nat Immunol 2007; 8: 1173–8PubMedView Article
  58. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085–8PubMedView Article
  59. Pulendran B, Ahmed R. Immunological mechanisms of vaccination. Nat Immunol 2011; 12: 509–17PubMedView Article
  60. Pulendran B, Tang H, Manicassamy S. Programming dendritic cells to induce T(H)2 and tolerogenic responses. Nat Immunol 2010; 11: 647–55PubMedView Article
  61. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229–41PubMedView Article
  62. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999; 354: 635–9PubMedView Article
  63. Rieg S, Steffen H, Seeber S, Humeny A, Kalbacher H, Dietz K, Garbe C, Schittek B. Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol 2005; 174: 8003–10PubMed
  64. Roll A, Cozzio A, Fischer B, Schmid-Grendelmeier P. Microbial colonization and atopic dermatitis. Curr Opin Allergy Clin Immunol 2004; 4: 373–8PubMedView Article
  65. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9: 313–23PubMedView Article
  66. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 2010; 107: 12204–9PubMedView Article
  67. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133: 775–87PubMedView Article
  68. Schöfer H. Evaluation of imiquimod for the therapy of external genital and anal warts in comparison with destructive therapies. Br J Dermatol 2007; 157 Suppl 2: 52–5PubMedView Article
  69. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, Gilliet M, Ho S, Antonenko S, Lauerma A, Smith K, Gorman D, Zurawski S, Abrams J, Menon S, McClanahan T, Waal-Malefyt R de, Bazan F, Kastelein RA, Liu YJ. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002; 3: 673–80PubMedView Article
  70. Traidl-Hoffmann C, Mariani V, Hochrein H, Karg K, Wagner H, Ring J, Mueller MJ, Jakob T, Behrendt H. Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. J Exp Med 2005; 201: 627–36PubMedView Article
  71. Trompette A, Divanovic S, Visintin A, Blanchard C, Hegde RS, Madan R, Thorne PS, Wills-Karp M, Gioannini TL, Weiss JP, Karp CL. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 2009; 457: 585–8PubMedView Article
  72. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027–31PubMedView Article
  73. Van Niel CW, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002; 109: 678–84PubMedView Article
  74. Vance RE, Isberg RR, Portnoy DA. Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe 2009; 6: 10–21PubMedView Article
  75. Volz T, Biedermann T. Allergologie Update 2010 — Tolerant sein oder nicht tolerant sein - das ist die zentrale Frage. In: Ruzicka T, Wolff H, Thomas P, Prinz J (Hrsg) Fortschritte der praktischen Dermatologie und Venerologie 2010. Berlin — Heidelberg — New York: Springer, 2011: 137–44
  76. Volz T, Biedermann T. Outside-in. Probiotische Externa. Hautarzt 2009; 60: 795–801PubMedView Article
  77. Volz T, Nega M, Buschmann J, Kaesler S, Guenova E, Peschel A, Röcken M, Götz F, Biedermann T. Natural Staphylococcus aureus-derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals. FASEB J 2010; 24: 4089–102PubMedView Article
  78. Volz T, Kaesler S, Biedermann T. Innate immune sensing 2.0 — from linear activation pathways to fine tuned and regulated innate immune networks. Exp Dermatol 2012; 21: 61–9PubMedView Article
  79. Weidinger S, Illig T, Baurecht H, Irvine AD, Rodriguez E, Diaz-Lacava A, Klopp N, Wagenpfeil S, Zhao Y, Liao H, Lee SP, Palmer CN, Jenneck C, Maintz L, Hagemann T, Behrendt H, Ring J, Nothen MM, McLean WH, Novak N. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006; 118: 214–9PubMedView Article
  80. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, Gordon JI, Chervonsky AV. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008; 455: 1109–13PubMedView Article
  81. Werfel T. Allergie und atopische Dermatitis — ausgewählte Aspekte aus Klinik und Forschung. Allergo J 2012; 21: 479–85View Article
  82. Werfel T, Aberer W, Augustin M, Biedermann T, Fölster-Holst R, Friedrichs F, Gieler U, Heratizadeh A, Kapp A, Przybilla B, Rietschel E, Schlaeger M, Schmid-Grendelmeier P, Sitters H, Staab D, Szczepanski R, Vieluf D, Voigtmann I, Worm M. Neurodermitis S2-Leitlinie. J Dtsch Dermatol Ges 2009; 7 Suppl 1: S1–46PubMed
  83. Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A, Dorschner RA, Bonnart C, Descargues P, Hovnanian A, Morhenn VB, Gallo RL. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 2007; 13: 975–80PubMedView Article
  84. Yan F, Polk DB. Commensal bacteria in the gut: learning who our friends are. Curr Opin Gastroenterol 2004; 20: 565–71PubMedView Article
  85. Yoo J, Omori M, Gyarmati D, Zhou B, Aye T, Brewer A, Comeau MR, Campbell DJ, Ziegler SF. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med 2005; 202: 541–9PubMedView Article
Metadaten
Titel
Welche Rolle spielt das natürliche Immunsystem bei atopischer Dermatitis?
Bestandsaufnahme und Ausblick
verfasst von
Thomas Volz
Prof. Dr. Tilo Biedermann
Publikationsdatum
05.01.2013
Verlag
Urban and Vogel
Erschienen in
Allergo Journal / Ausgabe 8/2012
Print ISSN: 0941-8849
Elektronische ISSN: 2195-6405
DOI
https://doi.org/10.1007/s15007-012-0443-7

Weitere Artikel der Ausgabe 8/2012

Allergo Journal 8/2012 Zur Ausgabe

AeDA/DGAKI informieren / Allergiekongress 2012

Preisträger von AeDA und DGAKI 2012

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.